2025-2034 Genomics Personalized Health Market Evolution: Disruptions, Innovations, and Untapped Opportunities

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Genomics Personalized Health Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of genomics personalized health has seen rapid expansion in the recent past. The market, which stood at $15.97 billion in 2024, is projected to reach $18.5 billion in 2025, with a compound annual growth rate (CAGR) of 15.9%. The notable growth during the historic period can be credited to the progress in genomics research, financial backing and endorsement from the government, an upsurge in chronic illnesses, technological advancements, investment from the pharmaceutical industry, and various collaborations and partnerships.

Genomics Personalized Health Market Size Forecast: What's the Projected Valuation by 2029?
The market size of genomics personalized health is anticipated to witness a rapid increase in the coming years, reaching $32.49 billion in 2029 with a compound annual growth rate (CAGR) of 15.1%. Factors that contribute to this growth over the forecast period include elevated healthcare investments, an increased use of genomics technologies, the expanded use of personalized medicine applications, a growing incidence of genetic disorders, biobank expansion, and a higher rate of chronic diseases. Key trends for the forecast period encompass integration with wearable technology, a surge in direct-to-consumer genetic testing, progress in CRISPR and gene editing technologies, the combination of genomics with digital health, and the broadening of precision medicine initiatives.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

What Are the Drivers Transforming the Genomics Personalized Health Market?
The uptick in demand for personalized medicine is projected to catalyze the expansion of the genomics personalized health market. Personalized medicine, sometimes known as precision medicine, is a healthcare approach that customizes medical treatments and practices for individual patient's unique characteristics. The move towards preventive healthcare, better treatment results, patient involvement and empowerment, economical advantages, and escalating incidents of chronic and complex conditions have all contributed to the increased demand for personalized medicine. Genomics personalized health greatly augments personalized medicine by harnessing individual genetic data in personalizing medical care, spanning from prevention and diagnosis to treatment and management. As an illustration, the Food and Drug Administration (FDA) authorized 16 fresh personalized therapies for patients afflicted with rare ailments in 2023, as stated by the US-based non-profit group, Personalized Medicine Coalition, in February 2024, which is a substantial increase from just six in 2022. Thus, the surging demand for personalized medicine is powering forward the demand for the genomics personalized health market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15814&type=smp

What Long-Term Trends Will Define the Future of the Genomics Personalized Health Market?
Leading organizations in the genomics personalized health market are concentrating on creating groundbreaking products, including cloud-based software for the tertiary assessment of clinical Next Generation Sequencing (NGS) data, to maintain a competitive position in the market. The term clinical Next Generation Sequencing (NGS) data pertains to the genetic data produced by sequencing technologies that permit an extensive, in-depth examination of DNA or RNA samples in a clinical environment. For example, in March 2023, Illumina, an American biotech firm that excels in DNA sequencing and array-based technologies, introduced Connected Insights. This is a cloud-based software tailored specifically for the tertiary examination of clinical Next Generation Sequencing (NGS) data. This platform's objective is to simplify interpretation and reporting aspects, with a special emphasis on oncology applications, and to support ample genomic profiling. The Connected Insights platform incorporates several third-party knowledge databases, which promotes accurate data assessment and boosts the effectiveness of precision care endeavors.

Which Segments in the Genomics Personalized Health Market Offer the Most Profit Potential?
The genomics personalized healthmarket covered in this report is segmented -

1) By Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Other Test Type
2) By Technology: NGS platforms, RT-PCR, Microarray, Genetic Analyzers
3) By End User: Academic Research Institutes, Diagnostic Centers, Other End Users

Subsegments:
1) Oncology Testing: Cancer Genomic Profiling, Liquid Biopsy Testing, Tumor Mutational Burden Testing, Genetic Biomarker Testing
2) Infectious Disease Testing: PCR-Based Tests, Next-Generation Sequencing (NGS) Tests, Microbial Genomic Profiling
3) Orphan Disease Testing: Genetic Screening For Rare Diseases, Genetic Testing For Inherited Disorders, Targeted Gene Panels
4) Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions, Immune System Gene Profiling, HLA Typing Tests
5) Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT), Genetic Screening For Birth Defects, Carrier Screening Tests
6) Other Test Type: Cardiovascular Genetic Testing, Neurological Disease Testing, Metabolic Disease Genetic Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15814&type=smp

Which Firms Dominate the Genomics Personalized Health Market by Market Share and Revenue in 2025?
Major companies operating in the genomics personalized health market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Quest Diagnostics, Agilent Technologies Inc., Lonza Group, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Personalis Inc., DNA Genotek Inc., Twist Bioscience Corporation, GRAIL Inc., Eastern Biotech and Life Sciences, INVITAE Corporation, Genetic Technologies Limited, XCode Life Sciences Private Limited, Biome Inc., BGI Genomics Co. Ltd.

Which Regions Offer the Highest Growth Potential in the Genomics Personalized Health Market?
North America was the largest region in the personalized health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15814

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.